Bengaluru, Oct. 6 -- A pharmaceutical stock gained nearly five percent, following news of a strategic acquisition. Investors reacted positively as the company moved to consolidate its stake in a key subsidiary, reflecting confidence in the company's expansion strategy and long-term growth potential.

Emcure Pharmaceuticals Ltd, has a market capitalization of Rs. 26,378.61 crore. The stock opened at Rs. 1,342.05, touched an intraday high of Rs. 1,414, and the previous close was Rs. 1,340.30, marking an intraday rise of 5.51 percent. Notably, Namita Thapar, holds a 2.68 percent stake in Emcure Pharmaceuticals.

What's the News?

The Board of Directors has approved the acquisition of 4,095,180 equity shares, representing 20.42 percent of the...